Ivermectin: A Closer Look at a Potential Remedy
Karim O Elkholy1, Omar Hegazy2, Burak Erdinc1
1Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Inhaled ivermectin may effectively treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by achieving targeted lung concentrations. This approach could offer a new therapeutic strategy for coronavirus disease 2019 (COVID-19) pneumonia.
Area of Science:
- Pharmacology
- Virology
- Respiratory Medicine
Background:
- The COVID-19 pandemic necessitates novel therapeutic strategies.
- Several antivirals, including remdesivir and favipiravir, are under investigation for SARS-CoV-2 treatment.
- Hydroxychloroquine trials were discontinued due to lack of survival benefit.
Purpose of the Study:
- To propose inhaled ivermectin as a potential treatment for SARS-CoV-2.
- To theorize achieving effective lung concentrations of ivermectin via inhalation.
Main Methods:
- Review of existing literature on ivermectin's antiviral properties.
- Theoretical modeling of inhaled ivermectin pharmacokinetics in the lungs.
Main Results:
- Ivermectin exhibits previously documented in vitro antiviral properties against SARS-CoV-2.
- Inhaled administration could potentially achieve therapeutic drug concentrations directly in the lungs.
Conclusions:
- Inhaled ivermectin presents a theoretical strategy to effectively target SARS-CoV-2 in the lungs.
- Further research is warranted to establish the survival benefit and efficacy of inhaled ivermectin for COVID-19.
More Related Videos
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
09:27A Rapid Strategy for the Isolation of New Faustoviruses from Environmental Samples Using Vermamoeba vermiformis
Published on: June 4, 2016
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Prevention of Further Absorption of Poison
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
